Full Text View
Tabular View
No Study Results Posted
Related Studies
SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
This study has been completed.
Study NCT00062803   Information provided by Sanofi-Aventis
First Received: June 16, 2003   Last Updated: April 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Embolism
Additional conditions recognized in this trial
Embolism
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
SR34006
(LMW)heparin
Warfarin VKA
Acenocoumarol VKA
Additional drug interventions recognized in this trial
Acenocoumarol
Heparin
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services